In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list - STAT

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its shortage list.

By: STAT

Oct 13 2024
0
0 Views

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lillys tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and,… [+1247 chars]

USDA: Nearly 10M pounds of ready-to-eat meat and poultry recalled due to listeria concerns - News 12 New Jersey

Elon Musk Says Robovan's Angular Design Inspired By Art Deco Trains, 'Unusually Low' Ground Clearance Enabled By Automatic Load-Leveling Suspension - Benzinga

JPMorgan and Wells Fargo Earnings Show the 2 Realities of the U.S. Economy - Barron's

Boeing to lay off 10% of staff, delay first 777X delivery - DW (English)

China flags more fiscal stimulus for economy, leaves out key details on size - Reuters

Prime Day Isn’t Over Yet; Amazon Reveals 10 Amazing Deals This Saturday Morning - Gizmodo

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network